pET-28b-T7-hAsCas12a-NLS(nucleoplasmin)-6xHis (BPK3541) Citations (1)

Originally described in: Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing.
Kleinstiver BP, Sousa AA, Walton RT, Tak YE, Hsu JY, Clement K, Welch MM, Horng JE, Malagon-Lopez J, Scarfo I, Maus MV, Pinello L, Aryee MJ, Joung JK Nat Biotechnol. 2019 Feb 11. pii: 10.1038/s41587-018-0011-0. doi: 10.1038/s41587-018-0011-0. PubMed Journal

---

Articles Citing pET-28b-T7-hAsCas12a-NLS(nucleoplasmin)-6xHis (BPK3541)

Articles
An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing. Ooi KH, Liu MM, Tay JWD, Teo SY, Kaewsapsak P, Jin S, Lee CK, Hou J, Maurer-Stroh S, Lin W, Yan B, Yan G, Gao YG, Tan MH. Nat Commun. 2021 Mar 19;12(1):1739. doi: 10.1038/s41467-021-21996-6. PubMed

If you have published an article using this material, please email us at to have your article added to this page.